Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer

Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer ORIGINAL ARTICLE Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer Ayesha S. Bryant, MSPH, MD,* and Robert James Cerfolio, MD, FACS, FCCP† lthough smoking rates have declined in the United States, Objective: Examination of factors that may contribute to racial Alung cancer continues to be a pandemic. It is the number disparity among those with lung cancer has been thwarted by one cause of cancer related deaths world-wide. In 2006 there heterogeneous treatment and staging strategies, limited national were an estimated 174,000 patients diagnosed with lung registry and socioeconomic and follow-up data. This study examines cancer and 162,000 deaths due to lung cancer in the United a decades worth of data to better elucidate these factors in a cohort States alone. Bronchogenic malignancy has been shown in staged or treated using homogeneous algorithms. large registry databases to have racial disparity in clinico- Methods: A nested case-control study of patients with non-small pathologic characteristics and in survival. However, these cell lung cancer (NSCLC). White patients were matched 4:1 to databases feature inconsistent staging, many different treating African American patients on age, gender, comorbidities, perfor- physicians, and multiple treatment strategies and a whole host mance status, and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer

Cerfolio, Robert James
Journal of Thoracic Oncology , Volume 3 (7) – Jul 1, 2008
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/impact-of-race-on-outcomes-of-patients-with-non-small-cell-lung-cancer-H6SVbHdrUS

References (32)

ISSN
1556-0864
DOI
10.1097/JTO.0b013e31817c60c7
pmid
18594315
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer Ayesha S. Bryant, MSPH, MD,* and Robert James Cerfolio, MD, FACS, FCCP† lthough smoking rates have declined in the United States, Objective: Examination of factors that may contribute to racial Alung cancer continues to be a pandemic. It is the number disparity among those with lung cancer has been thwarted by one cause of cancer related deaths world-wide. In 2006 there heterogeneous treatment and staging strategies, limited national were an estimated 174,000 patients diagnosed with lung registry and socioeconomic and follow-up data. This study examines cancer and 162,000 deaths due to lung cancer in the United a decades worth of data to better elucidate these factors in a cohort States alone. Bronchogenic malignancy has been shown in staged or treated using homogeneous algorithms. large registry databases to have racial disparity in clinico- Methods: A nested case-control study of patients with non-small pathologic characteristics and in survival. However, these cell lung cancer (NSCLC). White patients were matched 4:1 to databases feature inconsistent staging, many different treating African American patients on age, gender, comorbidities, perfor- physicians, and multiple treatment strategies and a whole host mance status, and

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Jul 1, 2008

There are no references for this article.